series-a
Stage
2
Investors
About
Abionic develops nanotechnology-based point-of-care diagnostic systems and rapid immunoassay tests, including the abioSCOPE platform used to detect biomarkers such as Pancreatic Stone Protein for early sepsis detection.
Explore Abionic's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.